 Psychedelics-focused biotech company Cybin Inc. NYSE:CYBN announced that it has formed a partnership with The Chopra Foundation, a not-for-profit founded by alternative medicine and new age author Deepak Chopra. The Foundation is working closely with Cybin to support education and awareness about its groundbreaking research to harness the potential of psychedelic therapies in mental health, the organization stated in a press release. 